---
title: "BMO raised the target price for Eli Lilly from $850 to $930"
description: "BMO raised the target price for Eli Lilly from $850 to $930"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/261862614.md"
published_at: "2025-10-20T10:58:21.000Z"
---

# BMO raised the target price for Eli Lilly from $850 to $930

BMO raised Eli Lilly's target price from $850 to $930

### Related Stocks

- [LLY.US - Eli Lilly](https://longbridge.com/en/quote/LLY.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| BMO Balanced ETF (Fixed Distr Units) declares CAD 0.049 dividend | BMO Balanced ETF (Fixed Distr Units) declares CAD 0.049 dividend | [Link](https://longbridge.com/en/news/276366133.md) |
| BMO Says Canada's Housing Construction Will Take Time To Pick Up | BMO Says Canada's Housing Construction Will Take Time To Pick Up | [Link](https://longbridge.com/en/news/276230710.md) |
| Couche-Tard Brief: BMO Says Co "Provided For a Slight Acceleration To Organic Growth From Recent Trend" | Couche-Tard Brief: BMO Says Co "Provided For a Slight Acceleration To Organic Growth From Recent Trend" | [Link](https://longbridge.com/en/news/275778205.md) |
| BMO Sees Loonie Appreciation Despite U.S. Trade Policy Risks | BMO Sees Loonie Appreciation Despite U.S. Trade Policy Risks | [Link](https://longbridge.com/en/news/276360918.md) |
| Couche-Tard Brief: Keeps Marketperform Rating, Target Raised To $84 at BMO On Takeaways From Co's 2026 Business Strategy Update | Couche-Tard Brief: Keeps Marketperform Rating, Target Raised To $84 at BMO On Takeaways From Co's 2026 Business Strategy | [Link](https://longbridge.com/en/news/275778147.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.